Limited-field radiotherapy as salvage treatment of localized persistent or recurrent epithelial ovarian cancer Journal Article


Authors: Davidson, S. A.; Rubin, S. C.; Mychalczak, B.; Saigo, P. E.; Lewis, J. L. Jr; Chapman, D.; Hoskins, W. J.
Article Title: Limited-field radiotherapy as salvage treatment of localized persistent or recurrent epithelial ovarian cancer
Abstract: Thirty-five patients with persistent or recurrent epithelial ovarian cancer were treated with salvage pelvic or para-aortic radiotherapy for disease limited to the pelvis (29), para-aortic retroperitoneum (5), or vaginal cuff (1). Prior therapy included a median of 3 chemotherapeutic drugs (range, 1-7) over a median of 12 cycles (range, 5-39); 12 patients had received intraperitoneal chemotherapy. The median number of prior laparotomies was 3 (range, 2-5). Including pelvic boosts, the median dose delivered to the treatment field was 4600 cGy (range, 4000-7000); 2 patients received additional treatment with a permanent 125I implant. All patients completed therapy, although 5 (14%) with grade 3 toxicity required a treatment break. Late bowel complications unrelated to recurrence occurred in 3 patients (9%). Median actuarial and progression-free survivals for all patients from start of radiotherapy were 40 and 14 months, respectively. At least 16 of 26 (62%) recurrences involved the treatment field. Multiple prognostic factors were evaluated in terms of recurrence, survival, and acute and chronic complications, but no significant prognosticators were detected. These findings indicate that limited-field salvage radiotherapy has an acceptable complication rate and may prolong the symptom-free survival interval in selected patients. © 1993 by Academic Press, Inc.
Journal Title: Gynecologic Oncology
Volume: 51
Issue: 3
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 1993-12-01
Start Page: 349
End Page: 354
Language: English
DOI: 10.1006/gyno.1993.1302
PROVIDER: scopus
PUBMED: 8112644
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Hoskins
    255 Hoskins
  2. Patricia E Saigo
    91 Saigo
  3. John   Lewis
    132 Lewis
  4. Stephen C. Rubin
    112 Rubin
  5. Douglass S. Chapman
    35 Chapman